Cite
MLA Citation
Yoshinobu Koguchi et al.. “760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A808. http://access.bl.uk/ark:/81055/vdc_100144730755.0x000009